Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,065–3,072 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
NRX Pharmaceuticals Inc. NRX-101 Post-traumatic stress disorder (PTSD) Phase 2 Trial Planned Oral Psychiatric
NuCana plc NUC-1031 (Acelarin) Pancreatic cancer Phase 3 Intravenous Oncology
NuCana plc Acelarin (NUC-1031) + Cisplatin - (NuTide:121) Advanced biliary tract cancer Phase 3 Intravenous Oncology
NuCana plc NUC-3373 (NuTide: 323) 2L Colorectal cancer Phase 2 Trial Discontinued Intravenous Oncology
NuCana plc NUC-1031 (Acelarin) Platinum-sensitive ovarian cancer Phase 2 Intravenous Oncology
Nurix Therapeutics Inc. Bexobrutideg - (DAYBreak CLL-306) Relapsed or refractory chronic lymphocytic leukemia (CLL) Phase 3 Trial Planned Oral Oncology
Nurix Therapeutics Inc. Bexobrutideg - (DAYBreak-CLL-201) Relapsed or Refractory Chronic Lymphocytic Leukemia Phase 2 Enrollment Initiation Oral Oncology
Nuvalent Inc. Zidesamtinib (NVL-520) - (ARROS-1) ROS1 Non-small cell lung cancer (NSCLC) PDUFA Data Released Oral Oncology